小児・成人の侵襲性肺炎球菌感染症の疫学情報

研究班の業績

HOME  >  研究班について  >  研究班の業績

小児疫学

  1. Oishi T, Ishiwada N, Matsubara K, Nishi J, Chang B, Tamura K, Akeda Y, Ihara T, Nahm MH, Oishi K, the Japanese IPD Study Group.　Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease.　Vaccine. 31: 845-9, 2013
  2. Ishiwada N, Hishiki H, Nagasawa K, Naito S, Sato Y, Chang B, Sasaki Y, Kimura K, Ohnishi M, Shibayama K. The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines. Vaccine. 32:5425-5431, 2014
  3. Chang B, Wada A, Hosoya M, Oishi T, Ishiwada N, Oda M, Sato T, Terauchi Y, Okada K, Nishi J, Akeda H, Kamiya H, Ohnishi M, Ihara T, and the Japanese Invasive Disease Study Group.Characteristics of group B Streptococcus isolated from infants with invasive infections: A population-based study in Japan. Jpn J Infect Dis. 67:356-360, 2014
  4. Tamura K, Matsubara K, Ishiwada N, Nishi J, Ohnishi H, Suga S, Ihara T, Chang B, Akeda Y, Oishi K; Japanese IPD Study Group. Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease.　Vaccine. 32: 1444-50, 2014
  5. Suga S, Chang B, Asada K, Akeda H, Nishi J, Okada K, Wakiguchi H, Maeda A, Oda M, Ishiwada N, Saitoh A, Oishi T, Hosoya M, Togashi T, Oishi K, Ihara T. Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine. Vaccine. 33, 6054-6060, 2015.
  6. Hoshino T, Hachisu Y, Kikuchi T, Tokutake S, Okui H, Kutsuna S, Fukasawa C, Murayama K, Oohara A, Shimizu H, Ito M, Takahashi Y, Ishiwada N. Analysis of Haemophilus influenzae serotype f isolated from three Japanese children with invasive H. influenzae infection. J Med Microbiol. 64: 355-8, 2015
  7. Suga S, Ishiwada N, Sasaki Y, Akeda H, Nishi J, Okada K, Fujieda M, Oda M, Asada K, Nakano T, Saitoh A, Hosoya M, Togashi T, Matsuoka M, Kimura K, Shibayama K. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.　Vaccine. 36:5678-5684, 2018.
  8. Sano T, Suzuki T, Nishigori A, Miyatake C, Koizumi S, Kaizu K, Fujita A, Kamisago M, Chang B, Ishiwada N, Asano T. The incidence of pediatric invasive bacterial diseases in Nippon Medical School Chiba Hokusoh Hospital before and after the introduction of conjugate vaccines. J Nippon Med Sch 85: 34-8, 2018
  9. Naito S, Takeuchi N, Ohkusu M, Takahashi-Nakaguchi A, Takahashi H, Imuta N, Nishi J, Shibayama K, Matsuoka M, Sasaki Y, Ishiwada N. Clinical and bacteriologic analysis of nontypeable Haemophilus influenzae strains isolated from children with invasive diseases, Japan, 2008-2015. J Clin Microbiol 56. pii: e00141-18, 2018
  10. Ohkusu M, Takeuchi N, Ishiwada N, Ohkusu K. Clonal spread of serotype 12F ST4846 Streptococcus pneumoniae. J Med Microbiol. 2019; 68:1383-90.
  11. Hoshino T, Takeuchi N, Ohkusu M, Hachisu Y, Hirose S, Fukasawa C, Kubota T, Ishida M, Watanabe H, Oishi K, Ishiwada N. Identification of Haemophilus influenzae serotype e strains missing the fucK gene in clinical isolates from Japan. J Med Microbiol. 68: 1534-9, 2019
  12. Kawabata T, Tenokuchi Y, Yamakuchi H, Sameshima H, Katayama H, Ohta T, Tokunaga M, Takezaki T, Tamae S, Nakamura T, Chang B, Kodama Y, Imuta N, Ooka T, Okamoto Y, Suga S, Nishi J. Concurrent Bacteremia Due to Non-vaccine Serotype 24F Pneumococcus in Twins: A Rapid Increase in Serotype 24F-invasive Pneumococcal Disease and its High Invasive Potential.　Pediatr Infect Dis J. 39(1):85-87, 2020
  13. Benett JC, Suga S, Hayford K, et al.　Changes in Invasive Pneumococcal Disease caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE project.　Microorganisms. 9(4):696, 2021
  14. Takeuchi N, Chang B, Takeshita K, Naito S, Takahashi Y, Hishiki H, Ishiwada N. Epidemiology and bacterial characteristics of invasive group B streptococcus disease: a population-based study in Japan in 2010-2020.　Epidemiol Infect. 150: e184, 2022.

成人疫学

  1. Fukusumi M, et al. Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: Disease characteristics and serotype distribution. BMC Infect Dis 2017 Jan 3; 17(1) : 2.
  2. Shimbashi R,et al. Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan. PLoS One 2019 Feb 21; 14(2) : e0212418.
  3. Shimbashi R, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in adults, Japan 2013-2017. Emerg Infect Dis. 2020, 26(19) : 2378-86.
  4. Chang B, et al. Distribution and variation of serotypes and pneumococcal surface protein A clades of Streptococcus pneumoniae strains isolated from adult patients with invasive pneumococcal disease in Japan. Front Cell Infect Microbiol. 2021, March 19; 11:617573.
  5. Garcia Quesada M, et al; The Pserenade Team. Serotype distribution of remaining pneumococcal meningitis in the mature PCV10/13 period: Findings from the PSERENADE Project. Microorganisms. 2021, 9(4) : 738.
  6. Deloria Knoll M, et al. Global landscape review of serotype-specific invasive pneumococcal disease Surveillance among countries using PCV10/13: The pneumococcal Serotype Replacement and distribution Estimation (PSERENADE) Project. Microorganisms. 9(4) : 742, 2021.
  7. Kuronuma K,et al.Invasive pneumococcal disease affected the fatal outcome in a COVID-19 patient.
    J Infect Chemother. 27(7) : 1108-11, 2021.
  8. Chang B, et al. Pneumococcal Meningitis in Adults in 2014−2018 after Introduction of Pediatric 13-valent Pneumococcal Conjugate Vaccine in Japan. Sci Rep 2022, Feb 23; 12(1) : 3066.
    doi: 10.1038/s41598-022-06950-w.
  9. Tamura K, et al. Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013–2019. Vaccine 2022, 40:3338-44.
    doi: 10.1016/j.vaccine.2022.04.062.
  10. Chang B, et al. Invasive Streptococcus oralis expressing serotype 3 pneumococcal capsule, Japan.
    Emerg Infect Dis 2022, 28(8)：1720-22.
  11. Hachisu Y, et al. Invasive Haemophilus influenzae Disease among Adults in Japan during 2014–2018.
    Infection. 2022 Jul 28. doi: 10.1007/s15010-022-01885-w. Infection 2023, 51(2) : 355-64.
  12. Tamura K,et al. Unveiling the role of preceding seasonal influenza in the development of bacteremic pneumococcal pneumonia in older adults before the COVID-19 pandemic in Japan. Int J Infect Dis 2024(in press)